Xconomy National

Archives

by in

Entry	Author	Date	Location
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News	Erin Kutz	02/03/12	Boston
Infinity Drug Fails in Pancreatic Cancer Trial, Shares Fall	Luke Timmerman	01/27/12	Boston
Why Biogen Idec Got Out of the Corporate VC Business	Luke Timmerman	01/27/12	Boston
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers	Erin Kutz	01/27/12	Boston
Infinity Offers Hint Of Effect With Pancreatic Cancer Drug	Luke Timmerman	01/20/12	Boston
Millennium: Takeda Acquires San Diego’s Intellikine for $190M Upfront	Luke Timmerman	12/20/11	Boston
The Genetics Institute Impact: Some Great Memories and Photos	Luke Timmerman	12/15/11	Boston
Infinity, Idera, Civitas, & More Boston-Area Life Sciences Headlines	Erin Kutz	12/02/11	Boston
Rib-X, Skyhook, Michael J. Fox Foundation & More Boston-Area Deals News	Erin Kutz	11/30/11	Boston
Infinity Pharmaceuticals Snags $50M Extension From Mundipharma	Luke Timmerman	11/29/11	Boston
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO	Luke Timmerman	11/03/11	Boston
Sha Mi, Biogen Idec’s Neurology Ace, to Join “The Genetics Institute Impact” on Dec. 14	Luke Timmerman	10/21/11	Boston
The Genetics Institute Impact: Join Mark Ptashne, Tom Maniatis & Gabe Schmergel on Dec. 14	Luke Timmerman	10/11/11	Boston
Encouraged by Early Work on Anti-Cancer Drug, Intellikine Hires New Head for Clinical Trials	Bruce V. Bigelow	07/18/11	San Diego
ASCO Wrap-Up: The Skinny on Cancer News From All Corners of the U.S.	Luke Timmerman	06/07/11	National
Ariad and Infinity to Reveal Data at ASCO, Excelimmune Gets $10.5M, Hologic Buys TCT, & More Boston-Area Life Sciences News	Erin Kutz	06/03/11	Boston
Infinity Dares to Think Big Against Pancreatic Cancer, Prepares to Show Early Results This Weekend	Luke Timmerman	06/02/11	Boston
Calistoga Hands the Keys to Gilead, Bets It Can Make Cancer a Chronic Disease Like HIV	Luke Timmerman	02/23/11	Seattle
Infinity Says Cash Stretches to 2014	Luke Timmerman	01/07/11	Boston
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News	Erin Kutz	01/07/11	Boston
Mike Huckman, Former CNBC Reporting Ace, Joins Stellar Lineup at Boston’s War on Cancer	Luke Timmerman	10/14/10	Boston
Where Will the Next Gleevec Come From? Xconomy Forum Looks At the Edge of Cancer R&D	Luke Timmerman	10/05/10	Boston
What Is Boston Doing for the War on Cancer? Find Out at Xconomy Forum on October 20	Luke Timmerman	08/25/10	Boston
How Novartis Got Its Vaccines Groove Back, Intellikine Gets a Drug Development Deal, Ambrx CEO Departs, & More San Diego Life Sciences News	Bruce V. Bigelow	07/15/10	San Diego
ThredUP Funded by New Micro VC Firm, Visterra Grabs $6M, Vivox Gets $2M From Peacock Equity, & More Boston-Area Deals News	Erin Kutz	07/14/10	Boston
After the Meltdown: Synta Pharma CEO Trumpets New Top Cancer Drug	Ryan McBride	07/12/10	Boston
AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News	Erin Kutz	07/09/10	Boston
Infinity Pharma, Intellikine Strike Deal to Make Cancer Drugs Against Hot Target	Luke Timmerman	07/08/10	Boston
Biogen Idec Reaches Deal With Icahn, Ironwood CEO Shares IPO Strategy, Luke Maps out the Genetics Institute Diaspora, & More Boston-Area Life Sciences News	Rebecca Zacks	03/26/10	Boston
The Genetics Institute Alumni: Where Are They Now?	Luke Timmerman	03/22/10	Boston
Page 1 of 3	next page »